The PDUFA action date for an FDA decision for linvoseltamab to treat adult patients with relapsed/refractory multiple myeloma ...

Acceptance follows resolution of third-party fill/finish manufacturing issuesFDA decision expected by July 10, 2025 TARRYTOWN, N.Y., Feb. 11, ...

CARsgen’s first enrolled subject in the THANK-u Plus platform-based allogeneic CAR-T trial achieves sCR at week 4: Shanghai, China Tuesday, February 11, 2025, 18:00 Hrs [IST] CA ...

Acceptance follows resolution of third-party fill/finish manufacturing issues FDA decision expected by July 10, 2025 TARRYTOWN, N.Y., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc.

Property tycoon Ong Beng Seng, who is facing two charges related to former Singapore transport minister S Iswaran’s case, has ...

Singapore's property magnate Ong Beng Seng, embroiled in a corruption case linked to former transport minister S. Iswaran, is ...

Billionaire hotelier Ong Beng Seng has been diagnosed with cancer. The 79-year-old has been undergoing chemotherapy for multiple myeloma, which is a type of blood cancer characterised by abnormal ...

SINGAPORE: Property tycoon Ong Beng Seng, who is facing two charges related to former transport minister S Iswaran's case, ...

Multiple myeloma (MM) is a malignant plasma cell disorder accounting for approximately 10% of all hematologic malignancies. The overall prognosis is driven by tumor biology but other factors such ...